What services does the Cloud Hospital platform provide?

The platform supports overseas marketing, patient reservations, payment management, follow-up care, and multilingual communication.

How many languages does the platform support?

Cloud Hospital supports 40 languages, including English, Japanese, Chinese, and Russian.

What type of platform is Cloud Hospital?

Cloud Hospital is a B2B Software-as-a-Service platform that supports hospitals in managing international patient engagement.

What Are the Latest Laser Treatments for Glaucoma?

The Latest Laser Treatments for Glaucoma: A Complete Guide

Glaucoma is a leading cause of irreversible blindness, affecting more than 80 million people worldwide. At its core, glaucoma damages the optic nerve, most often due to elevated intraocular pressure (IOP). While eye drops and oral medications have long been the mainstay of treatment, modern ophthalmology is experiencing a laser revolution—offering minimally invasive, effective, and patient-friendly solutions.

This article explores the latest laser treatments for glaucoma in 2025, their benefits, risks, and global adoption trends, with insights from clinical research and real-world practice.

Why Laser Treatment Is Changing the Game

Traditionally, glaucoma management involved:

Medications (eye drops, oral agents) to lower IOP
Conventional surgery (trabeculectomy, tube shunts) for advanced cases

The challenges with these older approaches are well-known:

Daily drops require lifelong adherence
Some medications cause side effects (redness, stinging, systemic reactions)
Surgeries carry higher complication risks and longer recovery times

Laser treatments bridge the gap—offering:

Outpatient, no-incision procedures
Minimal discomfort
Reduced or eliminated need for medications
Rapid recovery

Selective Laser Trabeculoplasty (SLT) – The Global First-Line Leader

SLT is the current gold standard for open-angle glaucoma laser therapy. It uses low-energy laser pulses targeting only pigmented trabecular meshwork cells. This stimulates biological changes that improve aqueous humor drainage.

Key Benefits:

Safe enough to be used as a first-line treatment
Repeatable if IOP rises again
Avoids thermal damage to surrounding tissues

Evidence Snapshot:

The LiGHT Trial found that 74% of newly diagnosed patients who started with SLT required no drops for at least three years.
A 6-year follow-up showed slower disease progression and fewer surgical interventions compared to the medication-first approach.

Real-World Example:
Mrs. Kim, a 58-year-old office worker in Seoul, opted for SLT after struggling with forgetfulness in her drop regimen. Post-procedure, her IOP dropped from 24 mmHg to 16 mmHg without medication, and she returned to work the next day.

Direct Selective Laser Trabeculoplasty (DSLT) – The New Arrival

DSLT, introduced in 2025, is an advanced evolution of SLT. It uses a non-contact delivery system and refined targeting algorithms for increased precision.

Why It Matters:

Even shorter procedure times
Potentially more uniform energy application
Less patient movement needed, which is ideal for elderly or anxious patients

Though still under study, early reports from centers like MUSC’s Storm Eye Institute suggest DSLT could become the preferred choice once long-term results are confirmed.

Excimer Laser Trabeculostomy (ELT) – The “Cold Laser” Approach

ELT creates micro-holes in the trabecular meshwork using a 308 nm excimer laser, which works via a photoablative (non-thermal) effect.

Advantages:

No thermal damage = less scarring
Long-lasting IOP reduction of 20–40% reported
Often combined with cataract surgery for efficiency

Global Status:
ELT is used in parts of Europe and gaining interest in Asia. U.S. adoption is slower due to regulatory hurdles, but interest is rising as new MIGS-compatible ELT devices are developed.

Cyclophotocoagulation (CPC) – Refining an Old Tool

Cyclophotocoagulation reduces aqueous humor production by treating the ciliary body.

Two modern, safer versions:

Micropulse Transscleral CPC (MP-TSCPC) – delivers energy in short pulses, allowing cooling periods to reduce tissue damage.
Endocyclophotocoagulation (ECP) – uses an endoscope during cataract surgery for direct visualization and targeted ablation.

Ideal For:

Advanced glaucoma where other treatments have failed
Patients who cannot tolerate further incisional surgery

Laser Peripheral Iridotomy (LPI) & Iridoplasty – Angle-Closure Solutions

For angle-closure glaucoma, LPI is a lifesaving intervention.
It creates a small opening in the iris to restore fluid flow between chambers of the eye. Iridoplasty, by contrast, uses laser burns to shrink peripheral iris tissue, widening the drainage angle.

Key Facts:

Quick, office-based procedures
LPI is often preventive in high-risk eyes (narrow angles detected on exam)
Low complication rates

Integration with Minimally Invasive Glaucoma Surgery (MIGS)

While MIGS is technically a surgical field, certain laser-assisted MIGS (like ECP) are blurring boundaries.
Combining laser trabeculoplasty with stent implantation or cataract surgery is increasingly common for maximum IOP control with minimal trauma.

Comparing the Main Laser Options

Treatment	Main Mechanism	Ideal Cases	Repeatable?	Downtime
SLT	Stimulates drainage	Open-angle glaucoma	Yes	1 day
DSLT	Enhanced SLT	Open-angle, emerging tech	TBD	1 day
ELT	Micro-openings in meshwork	Open-angle	No	1–2 days
MP-TSCPC	Reduce fluid production	Advanced/refractory	Yes	1–2 days
ECP	Target ciliary processes	Combined with cataract	No	1–2 days
LPI	Iris opening	Angle-closure	No	Hours
Iridoplasty	Iris reshaping	Narrow angles	Yes	Hours

Patient Journey – What to Expect

Before the Procedure:

Comprehensive eye exam
Gonioscopy to evaluate drainage angle
Baseline IOP measurements
Medication review (blood thinners may be paused)

During:

Outpatient setting, topical anesthesia
Procedure lasts 5–10 minutes (SLT/DSLT), up to 30 minutes for combined techniques
Minimal discomfort—often described as “light flickers”

After:

Temporary blurriness or mild redness
Anti-inflammatory drops for a few days
Return to normal activities within 24 hours

Follow-up:

IOP checked 1–2 weeks post-treatment
Periodic monitoring every few months

Risks and Considerations

While generally safe, laser treatments can have:

Mild eye inflammation
Temporary IOP spikes (more common in heavily pigmented angles)
Rare complications like corneal edema or sustained pressure rise

Patient Suitability:
Laser therapy is highly effective for many but may not replace surgery in very advanced or congenitally abnormal drainage systems.

Global Trends in 2025

SLT-first approach adopted in the UK, parts of Europe, and increasingly in Asia
DSLT expanding in North America and early adopters in East Asia
Micropulse CPC now preferred over continuous-wave CPC for its safety
Growing use of combined cataract + laser procedures in aging populations

Frequently Asked Questions (FAQ)

Q: Can laser treatment cure glaucoma?
A: No. It controls IOP and slows progression but cannot reverse existing optic nerve damage.

Q: How long does SLT last?
A: Effects can last 3–5 years on average, sometimes longer.

Q: Will I still need drops?
A: Many patients reduce or stop drops after laser therapy, but some will need combined treatment.

Q: Is it painful?
A: Most patients feel only mild discomfort, if any.

Q: Can laser be repeated?
A: SLT, DSLT, and micropulse CPC can be repeated; ELT and LPI usually are not.

The Future: AI and Personalized Laser Therapy

Researchers are exploring artificial intelligence-guided laser targeting and customized energy dosing based on each patient’s eye anatomy and pigment density. This could further improve precision and reduce variability in outcomes.

Final Thoughts

Laser therapy is not just an alternative—it is rapidly becoming the primary choice for many glaucoma patients worldwide. Techniques like SLT and the newer DSLT offer effective, safe, and repeatable options that can reduce dependence on drops, improve quality of life, and help preserve vision for years.

Patients considering laser therapy should consult a qualified ophthalmologist experienced in modern glaucoma management. With the right approach, laser treatment can be a pivotal step in preventing vision loss from this silent yet relentless disease.